Page last updated: 2024-10-24

candesartan and Brain Hemorrhage

candesartan has been researched along with Brain Hemorrhage in 4 studies

candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.

Research Excerpts

ExcerptRelevanceReference
"The Scandinavian Candesartan Acute Stoke Trial was a randomized- and placebo-controlled trial of candesartan in 2,029 patients with acute stroke and systolic blood pressure ≥140 mmHg."9.20Effects of candesartan in acute stroke on vascular events during long-term follow-up: results from the Scandinavian Candesartan Acute Stroke Trial (SCAST). ( Bath, PM; Berge, E; Boysen, G; Hornslien, AG; Igland, J; Murray, GD; Sandset, EC; Terént, A, 2015)
"The Scandinavian Candesartan Acute Stroke Trial (SCAST) indicated that blood pressure-lowering treatment with candesartan in the acute phase of stroke has a negative effect on functional outcome at 6 months, measured by the modified Rankin scale."9.20Effects of candesartan in acute stroke on activities of daily living and level of care at 6 months. ( Berge, E; Hornslien, AG; Sandset, EC; Wyller, TB, 2015)
"SCAST was a randomized- and placebo-controlled, double-masked trial of candesartan given for 7 days, in 2029 patients with acute stroke and systolic blood pressure ≥140 mm Hg."9.19Blood pressure-lowering treatment with candesartan in patients with acute hemorrhagic stroke. ( Bath, PM; Berge, E; Jusufovic, M; Sandset, EC, 2014)
"The Scandinavian Candesartan Acute Stroke Trial (SCAST) found no benefits of blood pressure-lowering treatment with candesartan in acute stroke."5.20Effects of blood pressure-lowering treatment in different subtypes of acute ischemic stroke. ( Bath, PM; Berge, E; Jusufovic, M; Sandset, EC; Sandset, PM, 2015)
"The Scandinavian Candesartan Acute Stoke Trial was a randomized- and placebo-controlled trial of candesartan in 2,029 patients with acute stroke and systolic blood pressure ≥140 mmHg."5.20Effects of candesartan in acute stroke on vascular events during long-term follow-up: results from the Scandinavian Candesartan Acute Stroke Trial (SCAST). ( Bath, PM; Berge, E; Boysen, G; Hornslien, AG; Igland, J; Murray, GD; Sandset, EC; Terént, A, 2015)
"The Scandinavian Candesartan Acute Stroke Trial (SCAST) indicated that blood pressure-lowering treatment with candesartan in the acute phase of stroke has a negative effect on functional outcome at 6 months, measured by the modified Rankin scale."5.20Effects of candesartan in acute stroke on activities of daily living and level of care at 6 months. ( Berge, E; Hornslien, AG; Sandset, EC; Wyller, TB, 2015)
"SCAST was a randomized- and placebo-controlled, double-masked trial of candesartan given for 7 days, in 2029 patients with acute stroke and systolic blood pressure ≥140 mm Hg."5.19Blood pressure-lowering treatment with candesartan in patients with acute hemorrhagic stroke. ( Bath, PM; Berge, E; Jusufovic, M; Sandset, EC, 2014)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jusufovic, M2
Sandset, EC4
Bath, PM3
Berge, E4
Sandset, PM1
Hornslien, AG2
Igland, J1
Terént, A1
Boysen, G1
Murray, GD1
Wyller, TB1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Scandinavian Candesartan Acute Stroke Trial[NCT00120003]Phase 32,500 participants (Anticipated)Interventional2005-06-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

4 trials available for candesartan and Brain Hemorrhage

ArticleYear
Blood pressure-lowering treatment with candesartan in patients with acute hemorrhagic stroke.
    Stroke, 2014, Volume: 45, Issue:11

    Topics: Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Double-Blind Method; Female; Huma

2014
Effects of blood pressure-lowering treatment in different subtypes of acute ischemic stroke.
    Stroke, 2015, Volume: 46, Issue:3

    Topics: Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Brain Ischemia; D

2015
Effects of candesartan in acute stroke on vascular events during long-term follow-up: results from the Scandinavian Candesartan Acute Stroke Trial (SCAST).
    International journal of stroke : official journal of the International Stroke Society, 2015, Volume: 10, Issue:6

    Topics: Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Brain Ischemia; F

2015
Effects of candesartan in acute stroke on activities of daily living and level of care at 6 months.
    Journal of hypertension, 2015, Volume: 33, Issue:7

    Topics: Activities of Daily Living; Aged; Aged, 80 and over; Antihypertensive Agents; Benzimidazoles; Biphen

2015